These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9231936)

  • 21. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Amaducci L; Baldereschi M; Doody R; Chandra V; Gaines AD
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():19-21. PubMed ID: 9305509
    [No Abstract]   [Full Text] [Related]  

  • 22. Community screening interview for dementia (CSI 'D'); performance in five disparate study sites.
    Hall KS; Gao S; Emsley CL; Ogunniyi AO; Morgan O; Hendrie HC
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):521-31. PubMed ID: 10861918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The French Addenbrooke's cognitive examination is effective in detecting dementia in a French-speaking population.
    Bier JC; Donckels V; Van Eyll E; Claes T; Slama H; Fery P; Vokaer M
    Dement Geriatr Cogn Disord; 2005; 19(1):15-7. PubMed ID: 15383740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Spanish translation and adaptation of the Uniform Data Set of the National Institute on Aging Alzheimer's Disease Centers.
    Acevedo A; Krueger KR; Navarro E; Ortiz F; Manly JJ; Padilla-Vélez MM; Weintraub S; López OL; Mungas D
    Alzheimer Dis Assoc Disord; 2009; 23(2):102-9. PubMed ID: 19474568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CERAD and NOSGER. Comparing predictive scales for dementia in a Swiss gerontopsychiatric patient population].
    Künig G; Kaldune A; Stief V; Jäger M; Hell D; Endrass J; Schreiter Gasser U
    Nervenarzt; 2007 Mar; 78(3):314, 316-21. PubMed ID: 16404633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The German language version of the Camberwell Assessment of Need for the Elderly (CANE) among dementia patients].
    Kaiser G; Unger A; Marquart B; Weiss M; Freidl M; Wancata J
    Neuropsychiatr; 2010; 24(3):182-9. PubMed ID: 20926056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Chinese Revised Algase Wandering Scale-Community Version for persons with dementia in northern Taiwan.
    Chiu YC; Hsu WC; Algase DL
    Aging Ment Health; 2011 Mar; 15(2):243-51. PubMed ID: 21337178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive approaches to early Alzheimer's disease diagnosis.
    Harrison J
    Med Clin North Am; 2013 May; 97(3):425-38. PubMed ID: 23642579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a short form of the Severe Impairment Battery.
    Saxton J; Kastango KB; Hugonot-Diener L; Boller F; Verny M; Sarles CE; Girgis RR; Devouche E; Mecocci P; Pollock BG; DeKosky ST
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):999-1005. PubMed ID: 16286444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards education-fair dementia screening.
    Iype T; Ajitha BK; Shaji KS
    Int Psychogeriatr; 2006 Dec; 18(4):757-8. PubMed ID: 17026783
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Meininger V; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):215-24; quiz 225-7. PubMed ID: 20739260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for cognitive impairment among older people in black and minority ethnic groups.
    Parker C; Philp I
    Age Ageing; 2004 Sep; 33(5):447-52. PubMed ID: 15217776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease.
    Thompson JC; Stopford CL; Snowden JS; Neary D
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):920-7. PubMed ID: 15965196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).
    Beck IR; Gagneux-Zurbriggen A; Berres M; Taylor KI; Monsch AU
    Arch Clin Neuropsychol; 2012 Aug; 27(5):510-9. PubMed ID: 22718104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological differentiation between Alzheimer's disease and dementia with Lewy bodies in a memory clinic.
    Kawai Y; Miura R; Tsujimoto M; Sakurai T; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Kachi T; Toba K
    Psychogeriatrics; 2013 Sep; 13(3):157-63. PubMed ID: 25913764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The 5-word test in 37 depressed patients compared with 36 normal controls and 35 patients with mild Alzheimer's disease].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Encephale; 2011 Apr; 37(2):127-32. PubMed ID: 21482230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.